These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 21071324)

  • 1. Longer-term implications of the generic prescription drug "price war".
    London PA
    J Am Pharm Assoc (2003); 2010; 50(6):758-60. PubMed ID: 21071324
    [No Abstract]   [Full Text] [Related]  

  • 2. Deeply discounted medications: Implications of generic prescription drug wars.
    Czechowski JL; Tjia J; Triller DM
    J Am Pharm Assoc (2003); 2010; 50(6):752-7. PubMed ID: 21071323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. $4 generics: How low, how broad, and why patient engagement is priceless.
    Rucker NL
    J Am Pharm Assoc (2003); 2010; 50(6):761-3. PubMed ID: 21071325
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of generic drug competition on the price of prescription drugs in Ontario.
    Lexchin J
    CMAJ; 1993 Jan; 148(1):35-8. PubMed ID: 8439888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicare Beneficiary Out-of-Pocket Costs for Generic Cardiovascular Medications Available Through $4 Generic Drug Discount Programs.
    Liu P; Dhruva SS; Shah ND; Ross JS
    Ann Intern Med; 2018 Dec; 169(11):817-819. PubMed ID: 30039170
    [No Abstract]   [Full Text] [Related]  

  • 6. Price competition in the Chinese pharmaceutical market.
    Wang YR
    Int J Health Care Finance Econ; 2006 Jun; 6(2):119-29. PubMed ID: 16783505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generic drug price war begins to benefit insurers.
    Sipkoff M
    Manag Care; 2009 Jan; 18(1):9-10. PubMed ID: 19186663
    [No Abstract]   [Full Text] [Related]  

  • 8. The importance of being first: evidence from Canadian generic pharmaceuticals.
    Hollis A
    Health Econ; 2002 Dec; 11(8):723-34. PubMed ID: 12457372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of generic substitution on price competition in Finland.
    Aalto-Setälä V
    Eur J Health Econ; 2008 May; 9(2):185-91. PubMed ID: 17508226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meeting resistance. Express Scripts-Medco deal called anti-competitive.
    Lee J
    Mod Healthc; 2011 Aug; 41(32):10-1. PubMed ID: 21879692
    [No Abstract]   [Full Text] [Related]  

  • 11. Choices in prescription-drug benefit programs: mail versus community pharmacy services.
    Kirking DM; Ascione FJ; Richards JW
    Milbank Q; 1990; 68(1):29-51. PubMed ID: 2215427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do generic firms and the Spanish public purchaser respond to consumer price differences of generics under reference pricing?
    Puig-Junoy J; Moreno-Torres I
    Health Policy; 2010 Dec; 98(2-3):186-94. PubMed ID: 20630613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Price regulation and generic competition in the pharmaceutical market.
    Dalen DM; Strøm S; Haabeth T
    Eur J Health Econ; 2006 Sep; 7(3):208-14. PubMed ID: 16841230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescription drug pricing: do competitive forces operate in the pharmaceutical marketplace?
    Margolis RE
    Healthspan; 1994 Feb; 11(2):9-16. PubMed ID: 10132991
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of local competition on the willingness of community pharmacies to supply medication therapy management services.
    Brooks JM; Klepser DG; Urmie JM; Farris KB; Doucette WR
    J Health Hum Serv Adm; 2007; 30(1):4-27. PubMed ID: 17557694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. By the numbers. Health plans and coverage of prescription drugs.
    Thornton D
    Healthplan; 1998; 39(6):77-8. PubMed ID: 10351351
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cost of drugs used to treat cardiovascular disease in Brazil].
    Bueno CS; Moreira AC; Oliveira KR
    Rev Panam Salud Publica; 2012 Jan; 31(1):62-7. PubMed ID: 22427166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of $4 generic prescription drug discount programs use in the low-income population.
    Omojasola A; Hernandez M; Sansgiry S; Paxton R; Jones L
    Res Social Adm Pharm; 2014; 10(1):141-8. PubMed ID: 23684716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restrictions on the reimbursement policy with regard to retail marketing of medicinal products in Poland.
    Zimmermann A
    Acta Pol Pharm; 2013; 70(2):339-43. PubMed ID: 23614291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.